Skip to main content
OpenTrials

Clinical trial condition

Blastic Plasmacytoid Dendritic Cell Neoplasm

Explore clinical trials studying Blastic Plasmacytoid Dendritic Cell Neoplasm. Study availability and eligibility vary by location and protocol.

33 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Blastic Plasmacytoid Dendritic Cell Neoplasm trial results

Recruiting

A Registry-study of ELZONRIS in Participants With BPDCN

NCT07785154

Conditions
Blastic Plasmacytoid Dendritic Cell Neoplasm, Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), Hematologic Diseases, +11 more
Locations
  • Medical University Innsbruck Innsbruck, Austria
  • Ordensklinikum Linz Krankenhaus der Elisabethinen Linz Linz, Austria
  • Salzburg Cancer Research Institute (SCRI) Salzburg, Austria
  • Medizinische Universitat Wien, Department for Internal Medicine I, Division of Hematology and Haemostaseology Vienna, Austria
View all 41 locations
View Trial Details
Recruiting

A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy

NCT07785180

Conditions
Blastic Plasmacytoid Dendritic Cell Neoplasm, Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), Hematologic Diseases, +11 more
Locations
  • Aarhus University Hospital Aarhus, Denmark
  • Odense University Hospital Odense, Denmark
  • Centre Hospitalier Universitaire Besancon Besançon, France
  • Hôpital Avicenne Bobigny, France
View all 67 locations
View Trial Details
Recruiting

Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Blastic Plasmacytoid Dendritic Cell Neoplasm Patients

NCT07007052

Conditions
Blastic Plasmacytoid Dendritic Cell Neoplasm, Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), Disease Attributes, +16 more
Locations
  • AMIENS - CH Amiens Picardie Site Sud Amiens, France
  • ANGERS - CHU - Maladies du sang Angers, France
  • ARGENTEUIL - Centre hospitalier Victor Dupouy Argenteuil, France
  • AVIGNON - Centre Hospitalier Avignon, France
View all 34 locations
View Trial Details
Recruiting

SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

NCT03113643

Conditions
Acute Myeloid Leukemia, Blastic Plasmacytoid Dendritic Cell Neoplasm, Bone Marrow Diseases, +16 more
Locations
  • City of Hope Duarte, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry

NCT05430971

Conditions
Blastic Plasmacytoid Dendritic Cell Neoplasm, Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), Hematologic Diseases, +11 more
Locations
  • Sylvester Comprehensive Cancer Center, University of Miami Miami, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Seattle Children's Cancer and Blood Disorders Center Seattle, Washington, United States
  • Hematology Center named after prof. R. Yeolyan Yerevan, Armenia
View all 22 locations
View Trial Details

Related conditions